IMTXImmatics N.V. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 17055
Ticker: IMTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-07-02
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: IMTX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,327,096,393.31
Shares outstanding (class): 134,096,576
Shares outstanding (weighted): 136,673,161
SIC: —
Employees: 407
Location: —
Homepage: https://www.immatics.com
Description: Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Market cap and share counts drift.

Funds holding this security

19 funds · 21 positions · $152.36M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$51.66M	0.64%	5,250,156 NS	TICKER
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$46.23M	0.50%	4,698,266 NS	TICKER
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$28.09M	0.65%	2,854,678 NS	TICKER
abrdn World Healthcare Fund —	—	$5.73M	1.19%	581,979 NS	TICKER
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$4.87M	0.04%	495,393 NS	TICKER
Wasatch Ultra Growth Fund WASATCH FUNDS TRUST	—	$4.47M	1.11%	454,537 NS	TICKER
Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC	—	$2.93M	0.50%	297,738 NS	TICKER
abrdn Life Sciences Investors —	—	$2.35M	0.42%	238,738 NS	TICKER
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.15M	0.09%	218,296 NS	TICKER
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$1.89M	0.01%	192,516 NS	TICKER
Small Company Value Trust John Hancock Variable Insurance Trust	—	$646.1K	0.50%	65,663 NS	TICKER
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$454.5K	0.06%	46,186 NS	TICKER
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$378.8K	0.06%	38,500 NS	TICKER
T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc.	TMED	$161.1K	0.79%	16,368 NS	TICKER
Health Sciences Trust John Hancock Variable Insurance Trust	—	$137.8K	0.06%	14,000 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERIMTX
CIK0001809196
ISINNL0015285941
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Immatics is a clinical-stage biopharmaceutical company focused on T-cell receptor-based immunotherapies, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.